Two novel human coronavirus OC43 genotypes circulating in hospitalized children with pneumonia in China

ABSTRACT

HCoV-OC43 is one of the mildly pathogenic coronaviruses with high infection rates in common population. Here, 43 HCoV-OC43 related cases with pneumonia were reported, corresponding genomes of HCoV-OC43 were obtained. Phylogenetic analyses based on complete genome, orf1ab and spike genes revealed that two novel genotypes of HCoV-OC43 have emerged in China. Obvious recombinant events also can be detected in the analysis of the evolutionary dynamics of novel HCoV-OC43 genotypes. Estimated divergence time analysis indicated that the two novel genotypes had apparently independent evolutionary routes. Efforts should be conducted for further investigation of genomic diversity and evolution analysis of mildly pathogenic coronaviruses.

KEYWORDS:

• HCoV-OC43
• hospitalized children
• pneumonia
• novel genotype
• recombinant

Introduction

There are four mildly pathogenic coronaviruses that can infect humans, HCoV-OC43, 229E, NL63 and HKU1, that mainly cause mild and self-limiting respiratory tract infections [1–4]. These mildly pathogenic coronaviruses were circulated endemically, contributing to episodes of human common cold worldwide and severe infection in immunosuppressed patients and infants [5,6]. HCoV-OC43 is the most prevalent HCoV in respiratory tract infections, which is believed to associate with fatal encephalitis [7]. Gene sequence of HCoV-OC43 showed a high similarity to bovine coronavirus and canine coronavirus [8]. 9-O-acetyl-sialic acid is believed to be the receptor to HCoV-OC43, which is the common receptor to Bovine CoV and HCoV-HKU1 [9].

Due to the capacity of coronaviruses to adapt to different hosts and make high-frequency mutations spontaneously in spike, it is easier for coronavirus to cross species barriers and enhance infectivity through successive generations [10]. Thus, it is urgently necessary to conduct virus genomic diversity and evolution investigation, especially for mildly pathogenic coronaviruses [11]. Here, a cluster of HCoV-OC43 related hospitalized children were enrolled in this study. The further genomic phylogenetic and evolution analysis of obtained sequences suggested two novel HCoV-OC43 genotypes (genotypes J and K) emerged in China. The discovery of novel HCoV-OC43 genotypes in human sheds light on the evolutionary trend and potential health threats of mildly pathogenic coronaviruses.

Methods

A total of 43 HCoV-OC43-positive (RT-PCR positive) children with pneumonia hospitalized in the First Affiliated Hospital of Guangzhou Medical University between 2009 and 2021 were enrolled in this study. Viral RNAs were extracted from patients’ nasopharyngeal swab and preprocessed according to the official recommended sequencing protocol. Sequencing and data processing were using Illumina NextSeq 550 (Illumina, San Diego, MD, USA). Contigs and consensus sequences were obtained by using CLC Genomics Workbench v11.0 (Qiagen, Germantown, MD, USA) based on HCoV-OC43 prototype strain (Accession Number: NC_006213.1). Phylogenetic analyses based on complete genome, orf1ab and spike genes were performed and analyzed by using the Neighbor-Joining method with 1000 bootstrap replicates in MEGA 5.1 software. Estimated divergence time analysis of genotypes was performed by Bayesian Evolutionary Analysis by Sampling Trees (BEAST v1.7.5) program to determine the most recent common ancestor (tMRCA) of the novel genotypes based on spike gene. Estimation of pairwise genetic distances was performed and analyzed by using the Neighbor-Joining method with 1000 bootstrap replicates in MEGA 5.1 software. Bootscan analysis in SimPlot software was used for potential recombination events detection.

Results

A cluster of 43 HCoV-OC43 infected children were enrolled in this study. The majority of patients who were infected with HCoV-OC43 had pneumonia, lobular pneumonia or acute bronchitis. Their ages ranged from 1.6 months to 8 years old. HCoV-OC43 RT-PCR positive samples were also tested for other 14 common respiratory pathogens, including HCoV-229E, HCoV-OC43, HCoV-HKU1, influenza A virus (Flu A), influenza B virus (Flu B), enterovirus (EV), human bocavirus (HBoV), human rhinovirus (HRV), respiratory syncytial virus (RSV), adenovirus (ADV), four types of human parainfluenza virus (HPIV), Mycoplasma pneumoniae (MP), human metapneumovirus (HMPV) and Chlamydia pneumonia (CP) [11]. Of the 43 patients, 26 (60.5%) of them were infected only with HCoV-OC43, while 17 (39.5%) patients were found to be co-infected with other pathogens (Supplementary Table 1). Only 45.2% (14/31) of subjects have settled in Guangzhou and others from all over the country.

After deleting overrepresented sequences, 38 HCoV-OC43 genome sequences of representative genotypes from the NCBI database with 43 HCoV-OC43 strains enrolled in this study were processed for the investigation of genetic relationship. As shown in Figure 1(A), all available HCoV-OC43 strains on NCBI can be divided into nine genotypes (A to I genotypes). However, two novel genotypes can be revealed after enrolling the genome sequences we acquired. Two novel genotypes, named genotype J and genotype K, occupy relatively independent positions in the phylogenetic tree. The time to a most recent common ancestor for the two genotypes was estimated to be between 4 and 6 years before the identification in 2014–2016. Besides, it is obvious that genotypes J and K were circulating simultaneously in 2019, and genotype K has become the dominant genotype gradually (Supplementary Table 1).

Figure 1. Analysis of time-resolved phylogeny, pairwise genetic distances and genetic recombination of two novel genotypes of HCoV-OC43. (A) Beast software was used to conduct estimated divergence time analysis of novel genotypes of HCoV-OC43 based on spike gene. A HKY nucleotide substitution model with estimated base frequencies and a lognormal relaxed clock model were used for evolution analysis. The Markov chain Monte Carlo (MCMC) analysis was performed with 1 × 109 generations with every 10,000 generations were sampled. The sampling year, strain name and accession number are shown on labels. Colour on branch represented the posterior probability corresponding to the legend. Two novel genotypes are indicated in green (J) and pink (K), respectively. (B) Estimation of pairwise genetic distances of novel genotypes J and K to previous genotypes based on the full-length genome sequences, respectively. (C) Genetic recombinant analyses of HCoV-OC43 novel genotypes J and K.

As shown in Figure 1(B), the genetic distance of the genotype J compared with genotypes A, B, C, D, E, F, G, and I were >0.5% (0.005 substitution/site), Phylogenetic trees based on spike and orf1ab gene showed different topologies associated with genotype J (Supplementary Figure 1). Recombination analysis also revealed that genotype J comes from the recombination between genotypes H and I (Figure 1(C), Supplementary Figure 1), while genotype K may be derived from genotype I. Above all, two novel genotypes of HCoV-OC43 associated with pneumonia emerged in China and showed different evolutionary routes.

Discussion

In this study, 43 sequences of HCoV-OC43 were enrolled for phylogenetic and evolution analysis, which revealed 2 novel genotypes circulating in China. HCoV-OC43 was circulated endemically, contributing to episodes of human common cold worldwide and severe infection in immunosuppressed patients and infants. However, the studies about HCoV-OC43 genomic diversity and evolution investigation are still rare due to the absence of enough genome sequence. There is no vaccine or specific treatment to protect against mildly pathogenic coronaviruses. Most people with mildly pathogenic human coronavirus illness will recover spontaneously, but people can have multiple infections in their lifetime. The discovery of two novel genotypes of HCoV-OC43 associated with pneumonia alarmed the significance of the monitoring common coronavirus variants.

Ethics statement

Sample collection and all experiments in the present study were performed with Ethical Approval given by Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University.

Acknowledgement

The authors thank the patients who took part in this study.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This study was funded by grants from the science and technology project of General Administration of Customs, P.R. China [grant numbers 2021HK141 LZ, 2019HK125 XBL], the national key research and development program of China [grant number 2020YFC1200100 JCZ], the Guangdong Provincial Department of Science and Technology [grant numbers 2020A1515010911 LZ, 2020A0505100063 JCZ, 201803040006 LZ], National Natural Science Foundation of China [grant numbers 81772191 JCZ, 91842106 JCZ, 82025001 JCZ and 8181101118, 32000658 LZ, 82172240 YQW], Guangdong-Hong Kong-Macau Joint Laboratory for Infectious Diseases [grant number GHMJLRID-Z-202114 YQW], State Key Laboratory of Respiratory Disease [grant number SKLRD-Z-202214 YQW], Guangzhou Medical University High-level University Innovation Team Training Program (Guangzhou Medical University released [2017] No. 159, JCZ).